SEARCH

SEARCH BY CITATION

References

  • 1
    Lunn DP , Davis-PoynterN, FlaminioMJBF, et al. Equine herpesvirus-1 consensus statement. J Vet Intern Med2009;23:450461.
  • 2
    APHIS Veterinary Services Info Sheet. Equine herpesvirus myeloencephalopathy: A potentially emerging disease. 2007. Available at: http://www.aphis.usda.gove/animal_health/emergingissues/downloads/ehv1final.pdf. Accessed February 2011.
  • 3
    Nugent J , Birch-MachinI, SmithKC, et al. Analysis of equid herpesvirus 1 strain variation reveals a point mutation of the DNA polymerase strongly associated with neuropathogenic versus nonneuropathogenic disease outbreaks. J Vir2006;80:40474060.
  • 4
    Allen GP. Risk factors for development of neurologic disease after experimental exposure to equine herpesvirus-1 in horses. Am J Vet Res2008;69:15951600.
  • 5
    Perkins GA , GoodmanLB, TsujimuraK, et al. Investigation of the prevalence of neurologic equine herpesvirus type 1 (EHV-1) in a 23-year retrospective analysis (1984–2007). Vet Micro2009;139:375378.
  • 6
    Henninger RW , ReedSM, SavilleWJ, et al. Outbreak of neurologic disease caused by equine herpesvirus-1 at a university equestrian center. J Vet Intern Med2007;21:157165.
  • 7
    Edington NWH , GriffithsL.The prevalence of latent equid herpesviruses in the tissues of 40 abattoir horses. Equine Vet J1994;26:140142.
  • 8
    Chester PM , AllsopR, PurewalA, EdingtonN, et al. Detection of latency-associated transcripts of equid herpesvirus 1 in equine leukocytes but not in trigeminal ganglia. J Vir1997;70:34373443.
  • 9
    Smith DJ , IqbalJ, PurewalA, et al. In vitro reactivation of latent equid herpesvirus-1 from CD5 +/CD8 + leukocytes indirectly by IL-2 or chorionic gonadotrophin. J Gen Vir1998;79:29973004.
  • 10
    Allen GP , BolinDC, BryantU, et al. Prevalence of latent, neuropathogenic equine herpesvirus-1 in the Thoroughbred broodmare population of central Kentucky. Equine Vet J2008;40:105110.
  • 11
    Pusterla N , MapesS, WilsonWD.Prevalence of equine herpesvirus type 1 in trigeminal ganglia and submandibular lymph nodes of equids examined postmortem. Vet Rec2010;167:376378.
  • 12
    Pusterla N , WilsonWD, MapesS, et al. Characterization of viral loads, strain and state of equine herpesvirus-1 using real-time PCR in horses following natural exposure at a racetrack in California. Vet J2009;179:230239.
  • 13
    Slater JD , BorchersK, ThackrayAM, FieldHJ.The trigeminal ganglion is a location for equine herpesvirus reactivation in the horse. J Gen Vir1994;75:20072016.
  • 14
    Yactor J , LunnKF, Traub-DargatzJL, et al. Detection of nasal shedding of EHV-1 & 4 at equine show events and sales by multiplex real-time PCR. Proceedings of the 52nd Annual Convention of the American Association of Equine Practice, San Antonio, TX, 2006, pp. 223–227.
  • 15
    Hinchcliff KW , RushBR, FarrisKW.Evaluation of plasma catecholamines and serum cortisol concentrations in horses with colic. J Am Vet Med Ass2005;227:276280.
  • 16
    Cohen ND , DiversTL.Acute colitis in horses. Part I. Assessment. Comp Cont Educ Pract Vet1998;20:9298.
  • 17
    Smith BP. Salmonella infection in hores. Compend Cont Educ Pract Vet1981;3:S417.
  • 18
    Pusterla N , MapesS, WilsonWD.Prevalence of equine herpesvirus type 1 in trigeminal ganglia and submandibular lymph nodes of equids examined postmortem. Vet Rec2010;167:376378.
  • 19
    Foote CE , GilkersonJR, WhalleyJM, LoveDN.Seroprevalence of equine herpesvirus 1 in mares and foals on a large Hunter Valley stud farm in years pre- and postvaccination. Aust Vet J2003;81:283288.